Minocycline accelerates recovery of sickness behavior score in septic rats

Read full text
Authors: Mariana Pereira de Souza Goldim, Richard Simon Machado, Aloir Neri de Oliveira, Leandro Garbossa, Taís Luise Denicol, Raquel Jaconi De Carli, Lucinéia Gainski Danielski, Fernanda Gava, Khiany Mathias, Naiana da Rosa, Jucélia Jeremias Fortunato, Cinara Ludvig Gonçalves
+1 more Fabricia Cardoso Petronilho
Cited by: 0
References: 41

Abstract

Objective: This study evaluated whether sickness behavior score (SBS) reflects neurochemical alterations and memory impairment in septic rats, and whether microglial activation contributes to these outcomes. Methods: Forty-eight male, 60-day-old Wistar rats (300–350 g) were evaluated daily after induction of sepsis by cecal ligation and perforation (CLP) or laparotomy (sham) in order to determine the involvement of microglial activation in the SBS. Animals received minocycline, an inhibitor of microglial activation, prior to surgery. Oxidative stress, IL-6 levels, markers of the hypothalamic–pituitary–adrenal axis, BDNF, and behavior were determined ten days after CLP. Results: The CLP + minocycline group showed a faster reduction in SBS (p < 0.001). Chronic sickness behavior was associated with brain levels of IL-6, nitrite/nitrate, and Brain-Derived Neurotrophic Factor (BDNF) and poorer performance on inhibitory avoidance behavioral tests (p < 0.05). Conclusion: Microglial activation and neuroinflammation occurring in sepsis may contribute to higher SBSs, reinforcing the score’s use to predict systemic and central septic severity.

Fields of Study & Subjects

Sepsis Diagnosis and Treatment Neuroinflammation and Neurodegeneration Mechanisms Tryptophan and brain disorders

Publication details

Journal / source
Academia Biology
Volume
4
Issue
1
Publication date
11 February 2026
Language
EN